Cardio Diagnostics is a medical technology company that develops artificial intelligence-powered blood tests for cardiovascular disease prevention and early detection using proprietary epigenetics-based diagnostic platforms. The company's core products include Epi+Gen CHD and PrecisionCHD, laboratory-developed blood tests that assess coronary heart disease risk, along with supporting platforms for clinical intelligence and population-level risk analytics. Cardio Diagnostics serves innovative health systems, employers, telemedicine platforms, and other healthcare channels, generating revenue by offering its tests through a CLIA-certified laboratory with insurance reimbursement and direct-pay models, and has identified substantial market opportunities in cardiovascular, stroke, heart failure, and diabetes screening and management.